Vext Science, Inc. (CSE:VEXT)
Canada · Delayed Price · Currency is CAD | Market Cap | 64.40M -25.7% |
| Revenue (ttm) | 71.97M +14.8% |
| Net Income | -20.44M |
| EPS | -0.08 |
| Shares Out | 247.71M |
| PE Ratio | n/a |
| Forward PE | 37.14 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,000 |
| Open | 0.2500 |
| Previous Close | 0.2450 |
| Day's Range | 0.2500 - 0.2600 |
| 52-Week Range | 0.1900 - 0.4000 |
| Beta | 0.89 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |
About Vext Science
Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brand... [Read more]
Financial Performance
In 2025, Vext Science's revenue was $51.37 million, an increase of 42.69% compared to the previous year's $36.00 million. Losses were -$17.99 million, -19.79% less than in 2024.
Financial numbers in USD Financial StatementsNews
Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
Ohio Division of Cannabis Control authorizes reopening of Jackson dispensary effective September 17 Single-day obligation at maturity reduced from approximately US$5.6 million to US$2.4 million, payab...
Vext Provides Operational Update on Jackson, Ohio Dispensary
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated ...
Vext Science Earnings Call Transcript: Q2 2026
Q2 saw flat sequential revenue but improved margins and profitability, driven by Ohio retail growth and the Arizona cultivation exit. Net loss narrowed 80% year-over-year, and cash flow remained strong. Focus remains on Ohio expansion, Arizona repositioning, and debt reduction.
Vext Science MD&A: Q2 2026
Vext Science filed a regulatory document on August 20, 2026 disclosing important business information.
Vext Science Report: Q2 2026
Vext Science published a report on August 20, 2026 containing material business information for investors and shareholders.
Vext Science Earnings release: Q2 2026
Vext Science released its Q2 2026 earnings on August 20, 2026, summarizing the period's financial results.
Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter
Revenue of $12.1 million, level with Q1 2026, as Ohio growth offset the planned Arizona cultivation wind-down. Adjusted EBITDA* of $3.4 million, up 22% from Q1 2026; net loss narrowed 79% year-over-ye...
Vext Announces Date for Q2 2026 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today anno...
Vext Opens Sixth Ohio Dispensary in Fairfield
A high-visibility location on one of the area's busiest retail corridors, anchored by neighboring Jungle Jim's International Market - expected to drive durable store-level performance. Vancouver, Brit...
Vext Science Earnings Call Transcript: Q1 2026
Revenue rose 5% year-over-year to $12.2M, led by Ohio's 34% growth, while Arizona declined 24% amid wholesale compression. Gross profit more than doubled, adjusted EBITDA margin improved to 29%, and net loss narrowed to $0.9M. Ohio retail expansion and Arizona streamlining remain key priorities.
Vext Science Earnings release: Q1 2026
Vext Science released its Q1 2026 earnings on May 21, 2026, summarizing the period's financial results.
Vext Science Report: Q1 2026
Vext Science published a report on May 21, 2026 containing material business information for investors and shareholders.
Vext Science MD&A: Q1 2026
Vext Science filed a regulatory document on May 21, 2026 disclosing important business information.
Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales
Revenue of $12.2 million, up 5.2% year-over-year; gross profit more than doubled to $5.5 million (45.4% margin), and net loss narrowed 73.2% to $(0.9) million. Operating cash flow of $1.6 million and ...
Vext Engages Zuanic & Associates
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with operations in Arizona and Ohi...
Vext Announces Date for Q1 2026 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announc...
Vext Science Slides: Investor presentation
Vext Science has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
Vext Science Earnings Call Transcript: Q4 2025
Revenue grew 43% year-over-year to $51.4M, with operating cash flow up 256% to $11.7M, driven by Ohio retail expansion. Arizona operations shifted to a retail-first model, exiting cultivation to optimize margins. DEA reclassification could materially reduce tax liabilities.
Vext Science Earnings release: Q4 2025
Vext Science released its Q4 2025 earnings on April 29, 2026, summarizing the period's financial results.
Vext Science Report: Q4 2025
Vext Science published a report on April 29, 2026 containing material business information for investors and shareholders.
Vext Science MD&A: Q4 2025
Vext Science filed a regulatory document on April 29, 2026 disclosing important business information.
Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales
Fiscal 2025 revenue of $51.4 million, up +43% YoY, with EBITDA* of $5 million and Adjusted EBITDA* of $10.9 million; net cash provided by operating activities of $11.7 million, up +256% (+$8.4 million...
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today annou...
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow. Proceeds from the sale to facilitate debt reduction, with key equi...
Vext Advances Ohio Expansion with Seventh Retail Location
Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals. Marks Vext's seventh dispensary in Ohio, and second in Colu...